home

GTHX.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

symbollastchange%chngnamemcapsectorwiki
GTHX
US
G1 Therapeutics Inc

Market global news for GTHX (US) G1 Therapeutics

Global news - US chevrons indicate local prediction, arrows show global predictions
Today
previous days
G1 Therapeutics to Participate in the TD Cowen 44th Annual
globenewswire - 16:15 Tue 27 - GTHX - link story
G1 Therapeutics (GTHX) Set to Announce Earnings on Wednesday
dailypolitical - 10:45 Tue 27 - GTHX - link story
G1 Therapeutics (GTHX) Set to Announce Earnings on Wednesday
tickerreport - 10:15 Tue 27 - GTHX - link story
G1 Therapeutics, Inc.'s (NASDAQ:GTHX) 47% loss last week hit both individual investors who own 60% as well as institutions
yahoo - 14:30 Sat 17 - GTHX - link story
G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024
wallstreet-online de - 15:45 Thu 15 - GTHX - link story
Rajesh Malik Sells 28,600 Shares of G1 Therapeutics, Inc. (NASDAQ:GTHX) Stock
defenseworld net - 11:15 Thu 15 - GTHX - link story
Rajesh Malik Sells 28,600 Shares of G1 Therapeutics, Inc. (NASDAQ:GTHX) Stock
modernreaders - 02:45 Wed 14 - GTHX - link story
G1 Therapeutics Shares Down 54% After Cancer Study Update, Wedbush Price Target Cut
marketwatch - 19:45 Tue 13 - GTHX - link story
Why Is G1 Therapeutics Stock Trading Lower Today? - G1 Therapeutics (NASDAQ:GTHX)
benzinga - 19:30 Tue 13 - GTHX - link story
Needham Adjusts G1 Therapeutics Price Target to $12 From $14, Maintains Buy Rating
marketscreener - 17:15 Tue 13 - GTHX - link story
Why Is G1 Therapeutics (GTHX) Stock Down 45% Today?
biztoc - 14:30 Tue 13 - GTHX - link story
Shares G1 Therapeutics Tumble 46% Following Update to Phase 3 Breast Cancer Study
marketwatch - 00:30 Tue 13 - GTHX - link story
G1 Therapeutics stock dives 36% post-market on P3 study update (NASDAQ:GTHX)
seekingalpha - 22:45 Mon 12 - GTHX - link story
G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data…
biztoc - 22:30 Mon 12 - GTHX - link story
G1 Therapeutics (GTHX) to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis
streetinsider - 22:00 Mon 12 - GTHX - link story
G1 Therapeutics' (GTHX) Buy Rating Reiterated at Needham & Company LLC
tickerreport - 17:45 Sat 27 - GTHX - link story
G1 Therapeutics (NASDAQ:GTHX) Stock Rating Reaffirmed by Needham & Company LLC
dailypolitical - 17:45 Sat 27 - GTHX - link story
G1 Therapeutics (NASDAQ:GTHX) Stock Rating Reaffirmed by Needham & Company LLC
wkrb13 - 05:00 Sat 27 - GTHX - link story